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MAIN
RNA-guided endonucleases, which consist of Clustered Regularly Interspaced Short
Palindromic Repeats (CRISPR) and CRISPR-associated proteins (Cas), have transformed genome engineering and are rapidly becoming indispensable tools in biomedical research. The programmable targeting capacity of Cas proteins has enabled applications that extend beyond genome editing, providing unprecedented new tools to control mammalian cell functions, including those which can regulate gene expression, modulate epigenetic landscapes, and manipulate chromatin structures 1 . These advances provide new opportunities for in vivo therapeutic applications, including recent demonstrations of dCas9 systems for gene therapy in rodent models of disease, such as diabetes, muscular dystrophy, and acute kidney disease [2] [3] .
Despite remarkable progress, significant hurdles remain that hinder practical applications of Cas technologies as in vivo tools and potential clinical therapies; these include off-target and offtissue effects and the lack of precise methods to deliver or control Cas9 expression in target tissues. Leveraging CRISPR technologies to create platforms that noninvasively manipulate transcript levels and tune dosing based on short input signals may increase the effectiveness of targeted approaches for controlling synthetic cellular phenotypes in vivo.
Toward this end, several inducible systems have been developed to provide the ability to modulate the activity of Cas9 and its variants in living animals [4] [5] . These include Cas9 systems that rely on chemical triggers using small molecule drugs, such as rapamycin and tamoxifen [6] [7] [8] , to activate and tune Cas9 activity by defined doses and at specific points in time. However, because these platforms rely on the systemic administration of chemical triggers to activate Cas-driven systems, they remain challenging to implement with spatial control. Alternatively, optical triggers offer noninvasive control of CRISPR-Cas9 that can be spatially defined by targeting with visible light [9] [10] . Without invasive interventions, however, the efficacy of this approach is limited to superficial targets due to poor light penetration into biological tissue.
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Here, we integrate heat as a remote trigger with the rapidly expanding CRISPR toolbox to confer tunable remote control of orthogonal transcriptional commands. In contrast to chemical or optical cues, pulses of heat can be delivered noninvasively with millimeter precision and at depth to anatomical sites by various approaches, such as infrared light 11 , high-intensity focused ultrasound 12 , or magnetic particles in alternating magnetic fields 13 . Recent control methods based on heat-induction to modulate gene expression [14] [15] [16] [17] . Here we construct heat-sensitive dCas9 systems to provide the ability to reversibly and dynamically modulate mammalian transcription under remote thermal control.
To establish a thermal Cas9 transcriptional modulator, we cloned catalytically-inactive Table 1) . We included MPH due to its ability to increase activation efficiency when it binds to MS2 loops on the sgRNA backbone 21 .
IL1RN, GzmB, and CCL21 were chosen for their diversity in function, as well as for their important roles across biological processes, such as cell signaling, apoptosis, and cell migration [22] [23] [24] . In accordance to our results that increasing trigger temperature leads to higher and 42°C heated implants (n=5-6, mean ± s.d., unpaired t-test, *p<0.05).
MATERIALS AND METHODS
Cell Culture
Human embryonic kidney (HEK) 293T cells were obtained from ATCC and maintained in 
Plasmid Design and Construction
All DNA constructs (Supplementary Figure 1) used were delivered to cells as plasmids. Unless otherwise noted, all restriction enzymes were obtained for New England Biolabs (Ipswich, MA).
All primers and sequencing verifications were obtained from Eurofins Genomics (Louisville, KY).
The hU6 promoter and the activating guide scaffold (sgRNA 2.0) 21 (IDT PAGE Ultramer) were simultaneously inserted into the pUC57 cloning vector (GenScript SD1176) by restriction enzyme digest using EcoRI, NsiI, and BamHI. The NsiI site was then removed using the Q5
Site-directed mutagenesis Kit (New England Biolabs, E0554S). All sgRNA sequences for 11 activation studies (Supplementary Table 1a ) were annealed and inserted via the BbsI restriction site. Subsequently, the hU6-sgRNA-activating scaffold sequences corresponding to endogenous genes were transferred into LeGO-C with constitutive expression of blue fluorescent protein, previously inserted using the BamHI and EcoRI restriction sites. The MPH construct (Addgene #61423) containing constitutive expression of eGFP was used for all activation experiments.
sgRNA sequences for suppression studies (Supplementary Table 1b) were inserted via the BbsI restriction site into eSpCas9(1.1) (Addgene #71814), which contains the human U6
promoter (hU6) and a standard guide scaffold (sgRNA 1.0) 21 . Using the XhoI and ApaI restriction sites, the hU6-sgRNA-suppresion scaffold sequences were subsequently transferred into the LeGO-C lentiviral backbone (Addgene #27348) with constitutive expression of a destabilized GFP variant (d2GFP), previously inserted using the BamHI and EcoRI restriction sites.
The promoter of the HSPA6 gene (Uniprot P17066) was amplified from human genomic DNA (Clontech #636401) from -1231 bp to +119 bp relative to the transcriptional start site, as previously described
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. The dCas9 variants (Addgene 47107, 21916) were placed under the control of the heat shock promoter via restriction enzyme cloning using AgeI and XhoI in LeGO-C. For d2GFP suppression studies, the mCherry reporter was replaced with Thy1.1 (Uniprot P01831) (Supplementary Figure 1) .
Validation of sgRNAs for d2GFP Suppression
One day prior to transfection, d2GFP-expressing HEK293T cells were seeded in a 6-well plate at a density of 2. Supplementary Figure 6 ) was used for all subsequent suppression studies.
Viral Production and Generation of Stable Cell Lines
Plasmid DNA was purified using with either E.Z. 
In vivo suppression of d2GFP
All animal studies were approved by the Institutional Animal Care and Use Committee at Georgia Institute of Technology. Gold nanorods (AuNRs) were synthesized as previously were used in 10 μL reactions in quadruplicates in a 384-well format. Relative levels of cDNA were detected using QuantStudio TM 6 Flex Real-Time PCR System (Applied Biosciences). Raw data was normalized to GAPDH levels and untreated (37°C) controls using the ΔΔCt method.
Analyzed data are reported as mean ± s.d.
Statistical analysis
All results are presented as mean and error bars show standard deviation. Statistical analysis was performed using statistical software (GraphPad Prism 6; GraphPad Software). *P < 0.05, **
